EGFR and non-small cell lung carcinoma: CT imaging combined with clinical characteristics has been systematically analyzed to predict EGFR mutations in NSCLC (8), with positron emission tomography/computed tomography (PET/CT) now widely applied to assess NSCLC patients undergoing targeted treatment.